Home Interviews Alligator’s CEO: “I’m confident that we will strike a deal”

Alligator’s CEO: “I’m confident that we will strike a deal”

Alligator’s CEO: “I’m confident that we will strike a deal”

30 January, 2025

Alligator Bioscience is currently conducting a rights issue aimed at advancing mitazalimab towards phase III and securing a partnership. CEO Søren Bregenholt joins BioStock’s studio to discuss the recently announced cost-saving program, mitazalimab’s clinical data, and the company’s efforts to achieve a partnership for the candidate.
– A number of companies are doing due diligence, says Søren Bregenholt.

Watch the interview below:

YouTube video

This material has been prepared for marketing purposes and is not, and should not be considered, a prospectus according to applicable laws and regulations. The complete terms of the rights issue and more information about the company have been presented in a prospectus that has been disclosed and published on the aforementioned company’s website.

Artikelns innehåll är sponsrat av det aktuella bolaget som förekommer i texten. BioStock tillhandahåller inte investeringsrådgivning, förmedlar inga investeringsorder och tar inget ansvar för agerande och/eller eventuell förlust eller skada av något slag som grundar sig på användandet av innehåll som publicerats på BioStock.se. Varje investeringsbeslut fattas istället självständigt av den enskilde investeraren.

Prenumerera på BioStocks nyhetsbrev

Share this!